Search by Drug Name or NDC

    NDC 47335-0673-81 Diltiazem Hydrochloride 360 mg/1 Details

    Diltiazem Hydrochloride 360 mg/1

    Diltiazem Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is DILTIAZEM HYDROCHLORIDE.

    Product Information

    NDC 47335-0673
    Product ID 47335-673_ecddf1f1-b8e7-4a08-8f00-6cc484092a5f
    Associated GPIs 34000010117060
    GCN Sequence Number 024478
    GCN Sequence Number Description diltiazem HCl CAP SA 24H 360 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 02328
    HICL Sequence Number 000182
    HICL Sequence Number Description DILTIAZEM HCL
    Brand/Generic Generic
    Proprietary Name Diltiazem Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Diltiazem Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 360
    Active Ingredient Units mg/1
    Substance Name DILTIAZEM HYDROCHLORIDE
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090421
    Listing Certified Through 2024-12-31

    Package

    NDC 47335-0673-81 (47335067381)

    NDC Package Code 47335-673-81
    Billing NDC 47335067381
    Package 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (47335-673-81)
    Marketing Start Date 2010-11-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.60934
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DILTIAZEM 24HR ER 360 MG CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis